TRANSITION AND ADVISORY AGREEMENT AND RELEASETransition and Advisory Agreement • August 7th, 2023 • Viatris Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2023 Company Industry JurisdictionThis TRANSITION AND ADVISORY AGREEMENT AND RELEASE (this “Agreement”) is entered into and effective as of May 19, 2023, by and between Viatris Inc. (“Viatris” or the “Company”) and Robert J. Coury (“Executive”).
OMNIBUS AMENDMENT NO. 1Transaction Agreement • August 7th, 2023 • Viatris Inc • Pharmaceutical preparations
Contract Type FiledAugust 7th, 2023 Company IndustryThis OMNIBUS AMENDMENT NO. 1, effective as of May 17, 2023 (this “Amendment”), is by and among Viatris Inc., a Delaware corporation (“Viatris”), Biocon Biologics UK Limited, a U.K. private limited company (“Biocon UK”), Biosimilar Collaborations Ireland Limited, an Irish private limited company (“Biosimilar Collaborations”), Biosimilars Newco Limited, a U.K. private limited company (“Biosimilars Newco”), and Biocon Biologics Limited, a public limited company incorporated under the Indian Companies Act, 2013 (“Biocon”). Each of the parties hereto is referred to individually as a “Party” and collectively as the “Parties.”